Cite
Ardizzone S, Ferretti F, Monico MC, et al. Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy. J Gastroenterol Hepatol. 2021;36(11):3050-3055doi: 10.1111/jgh.15591.
Ardizzone, S., Ferretti, F., Monico, M. C., Carvalhas Gabrielli, A. M., Carmagnola, S., Bezzio, C., Saibeni, S., Bosani, M., Caprioli, F., Mazza, S., Casini, V., Cortelezzi, C. C., Parravicini, M., Cassinotti, A., Cosimo, P., Indriolo, A., Di Sabatino, A., Lenti, M. V., Pastorelli, L., Conforti, F., Ricci, C., Sarzi-Puttini, P., Vecchi, M., & Maconi, G. (2021). Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy. Journal of gastroenterology and hepatology, 36(11), 3050-3055. https://doi.org/10.1111/jgh.15591
Ardizzone, Sandro, et al. "Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy." Journal of gastroenterology and hepatology vol. 36,11 (2021): 3050-3055. doi: https://doi.org/10.1111/jgh.15591
Ardizzone S, Ferretti F, Monico MC, Carvalhas Gabrielli AM, Carmagnola S, Bezzio C, Saibeni S, Bosani M, Caprioli F, Mazza S, Casini V, Cortelezzi CC, Parravicini M, Cassinotti A, Cosimo P, Indriolo A, Di Sabatino A, Lenti MV, Pastorelli L, Conforti F, Ricci C, Sarzi-Puttini P, Vecchi M, Maconi G. Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy. J Gastroenterol Hepatol. 2021 Nov;36(11):3050-3055. doi: 10.1111/jgh.15591. Epub 2021 Jul 05. PMID: 34159648; PMCID: PMC8447454.
Copy
Download .nbib